Your browser is no longer supported. Please, upgrade your browser.
Settings
MNK Mallinckrodt plc daily Stock Chart
MNK [NYSE]
Mallinckrodt plc
Index- P/E- EPS (ttm)-42.76 Insider Own0.60% Shs Outstand84.75M Perf Week2.59%
Market Cap402.56M Forward P/E0.68 EPS next Y7.04 Insider Trans0.00% Shs Float81.76M Perf Month-8.12%
Income-3564.00M PEG- EPS next Q2.05 Inst Own93.50% Short Float53.82% Perf Quarter53.72%
Sales3.19B P/S0.13 EPS this Y-421.90% Inst Trans-2.44% Short Ratio5.49 Perf Half Y11.24%
Book/sh36.67 P/B0.13 EPS next Y-18.25% ROA-33.90% Target Price5.55 Perf Year-77.97%
Cash/sh5.89 P/C0.81 EPS next 5Y- ROE-117.60% 52W Range1.43 - 27.33 Perf YTD36.10%
Dividend- P/FCF0.72 EPS past 5Y2.23% ROI-36.70% 52W High-84.56% Beta2.67
Dividend %- Quick Ratio0.90 Sales past 5Y14.30% Gross Margin44.20% 52W Low195.10% ATR0.79
Employees3700 Current Ratio1.10 Sales Q/Q-7.00% Oper. Margin- RSI (14)43.88 Volatility34.72% 14.83%
OptionableYes Debt/Eq1.87 EPS Q/Q-100.90% Profit Margin- Rel Volume1.13 Prev Close4.75
ShortableYes LT Debt/Eq1.64 EarningsFeb 25 BMO Payout- Avg Volume8.02M Price4.22
Recom3.10 SMA20-13.99% SMA50-2.77% SMA200-20.28% Volume8,280,054 Change-11.16%
Sep-05-19Reiterated BofA/Merrill Underperform $5 → $1
Sep-05-19Downgrade BMO Capital Markets Outperform → Market Perform
Sep-03-19Reiterated Berenberg Sell $5 → $1
Jun-11-19Initiated Barclays Equal Weight
May-31-19Downgrade Piper Jaffray Overweight → Neutral
May-22-19Downgrade Jefferies Buy → Hold
Mar-20-19Initiated SunTrust Hold
Nov-19-18Upgrade Canaccord Genuity Hold → Buy $34 → $40
Sep-11-18Downgrade Goldman Neutral → Sell
Aug-24-18Reiterated B. Riley FBR Neutral $20 → $37
Aug-08-18Reiterated Stifel Hold $18 → $30
Aug-08-18Downgrade Raymond James Outperform → Mkt Perform
May-09-18Reiterated Barclays Underweight $20 → $12
May-02-18Initiated B. Riley FBR, Inc. Neutral $15
Mar-09-18Reiterated Mizuho Neutral $21 → $16
Feb-02-18Downgrade Barclays Equal Weight → Underweight $23 → $20
Jan-09-18Reiterated Mizuho Neutral $22 → $21
Jan-03-18Initiated Leerink Partners Mkt Perform $26
Nov-08-17Reiterated Canaccord Genuity Buy $38 → $24
Nov-08-17Downgrade Wells Fargo Outperform → Market Perform
Feb-26-20 02:49PM  Mallinckrodt Gains on Opioid Settlement, Beats on Q4 Earnings Zacks -11.16%
01:18PM  Mallinckrodt gets 'much needed clarity' in $1.6B opioid settlement: Analysts American City Business Journals
05:48AM  Generic drugmakers sold most opioids during overdose crisis MarketWatch
05:00AM  Drugmaker Mallinckrodts Opioid Plan: Sacrifice a Part to Save the Whole Bloomberg
Feb-25-20 04:27PM  Mallinckrodt Unveils $1.6 Billion Opioid Deal And Generic Stocks Pop Investor's Business Daily +13.91%
11:14AM  Stocks tumble Tuesday after suffering their worst day in two years MarketWatch
10:03AM  Mallinckrodt Rips Higher After Company Confirms $1.6B Opioid Litigation Settlement Benzinga
08:56AM  Mallinckrodt Stock Is Soaring After the Company Agreed to Settle Opioid Lawsuits Barrons.com
08:28AM  The Daily Biotech Pulse: Moderna Ships COVID-19 Vaccine For Clinics, Mallinckrodt Strikes $1.6B Opioid Settlement Benzinga
08:23AM  Mallinckrodt reaches $1.6B opioid settlement calling for generics unit bankruptcy American City Business Journals
08:19AM  Mallinckrodt Stock Soars and Palo Alto Plummets as the Dow Looks Set to Rise Barrons.com
08:05AM  Benzinga Pro's Top 5 Stocks To Watch For Tues., Feb. 25, 2020: NIO, TUP, PANW, MRNA, MNK Benzinga
07:44AM  Mallinckrodt agrees to $1.6 billion opioid settlement, unit to seek bankruptcy Reuters
07:30AM  Mallinckrodt (MNK) Surpasses Q4 Earnings and Revenue Estimates Zacks
07:23AM  Mallinckrodt Surges After $1.6 Billion Opioid Claims Settlement Bloomberg
06:37AM  Mallinckrodt's stock bounces after opioid-related settlement deal, earnings that beat expectations MarketWatch
06:30AM  Mallinckrodt Plc to Host Earnings Call ACCESSWIRE
06:05AM  Mallinckrodt plc Reports Strong Fourth Quarter and 2019 Results PR Newswire
06:00AM  Mallinckrodt Announces Agreement in Principle for Global Opioid Settlement and Associated Debt Refinancing Activities PR Newswire
Feb-24-20 03:40PM  Mallinckrodt Shares Plunge Following Bankruptcy Report Bloomberg -18.55%
02:48PM  Mallinckrodt proposes $1.6 billion opioid deal, Chapter 11 for generics unit: WSJ Reuters
02:46PM  Mallinckrodt's stock suffering record selloff after WSJ report of talks with creditors MarketWatch
10:12AM  Why Mallinckrodt (MNK) Might Surprise This Earnings Season? Zacks
Feb-14-20 07:38AM  Mallinckrodt to Report Earnings Results for Fourth Quarter and Fiscal 2019 PR Newswire -8.92%
Feb-10-20 02:43PM  New York Opioid Case A Significant Risk For Pharma Stocks, Says Bearish BofA Benzinga
Feb-06-20 03:34PM  4 Stocks Looking Higher During Earnings Season Benzinga
12:10PM  Will Mallinckrodt (MNK) Beat Estimates Again in Its Next Earnings Report? Zacks
11:17AM  Four stocks to watch this week include Clovis Oncology and 3D Systems MarketWatch
08:40AM  Implied Volatility Surging for Mallinckrodt (MNK) Stock Options Zacks
Jan-22-20 02:48PM  This local regenerative medicine company is plotting its IPO American City Business Journals -7.45%
Jan-20-20 09:30AM  Should Value Investors Consider Mallinckrodt (MNK) Stock? Zacks
08:17AM  J&J's $8B Jury Award in Risperdal Case Cut to $6.8M by Judge Zacks
Jan-15-20 01:55PM  Mallinckrodt's stocks soars on heavy volume toward near-40% gain this week after comments at broker conference MarketWatch +25.42%
Jan-13-20 09:11AM  Endo Up on Opioid Abuse Settlement Agreement With Oklahoma Zacks
Dec-30-19 09:12AM  Will J&J be Able to Overcome Its Legal Troubles in 2020? Zacks
Dec-23-19 06:45AM  Mallinckrodt to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire -5.21%
Dec-19-19 06:00AM  These Are the Trades That Gutted Bonuses This Year Bloomberg
Dec-17-19 10:25AM  Mallinckrodt Initiates Phase IV Study on Acthar for Keratitis Zacks
Dec-16-19 04:45PM  First Patient Enrolled in Mallinckrodt Phase 4 Trial of Acthar® Gel (Repository Corticotropin Injection) for Severe Keratitis PR Newswire
Dec-11-19 08:52AM  Implied Volatility Surging for Mallinckrodt (MNK) Stock Options Zacks
Dec-10-19 12:49PM  A Word of Caution for 2 Underperforming Stocks GuruFocus.com
06:45AM  Mallinckrodt Announces Plans to Update Its Incentive Compensation Clawback Policy and Create Opioid Report PR Newswire
Dec-09-19 10:04AM  Mallinckrodt International Finance SA -- Moody's downgrades Mallinckrodt's CFR to Caa2; considers transaction a distressed exchange Moody's
Dec-07-19 12:05PM  Mallinckrodt Presents Data on a Novel Predictive Model to Identify Infants at Risk for Infantile Spasms (IS) at the 2019 Annual Meeting of the American Epilepsy Society (AES) PR Newswire
Dec-06-19 11:33AM  Two St. Louis companies make list of 15 worst corporate deals American City Business Journals
Dec-05-19 11:31AM  Mallinckrodt (MNK) Up 28.5% Since Last Earnings Report: Can It Continue? Zacks -12.89%
06:45AM  Mallinckrodt plc Announces Final Results of Exchange Transactions PR Newswire
Dec-04-19 07:59AM  J&J's (JNJ) New Tests Reveal No Asbestos in Baby Powders Zacks +6.59%
Dec-02-19 07:20PM  Mallinckrodt Moves Date and Time of Its Fireside Chat at Piper Jaffray Annual Healthcare Conference PR Newswire
Nov-27-19 12:36PM  Possible criminal probe undermines recovery in opioid stocks since global legal settlement announced MarketWatch +6.05%
09:37AM  Opioid Stocks Fall on News of Federal Criminal Investigation Barrons.com
08:42AM  Benzinga Pro's Stocks To Watch For Wednesday, Nov. 27th, 2019: DE, ADSK, GES, MNK, AMZN Benzinga
07:34AM  Fed Reportedly Opens Criminal Investigation on Opioid Makers Zacks
06:14AM  Pharma Companies Shares Tank As Feds Investigate Opioid Crisis Benzinga
Nov-26-19 01:21PM  Shares of opioid makers and distributors drop on criminal probe MarketWatch
07:08AM  Shares of generic drugmakers rise on hope that legal issues are nearing an end MarketWatch
06:45AM  Data on Acthar® Gel (Repository Corticotropin Injection) Therapy in Symptomatic Sarcoidosis Published in Therapeutic Advances in Respiratory Disease PR Newswire
Nov-25-19 12:49PM  Shares of generic drugmakers jump in morning trading MarketWatch +11.42%
12:39PM  Arnold Schneider Trims Positions in Chesapeake, Citigroup GuruFocus.com
Nov-21-19 03:20PM  Endo's (ENDP) BLA for Cellulite Treatment Accepted by FDA Zacks
07:00AM  Market Morning: GM Sues Fiat, Pharma Fights for Pricing Privacy, More Opioid Lawsuits, Trade Deal Troubles Market Exclusive
02:40AM  Edited Transcript of MNK earnings conference call or presentation 5-Nov-19 1:30pm GMT Thomson Reuters StreetEvents
Nov-19-19 08:38PM  Mallinckrodt plc Announces Early Results of Exchange Transactions PR Newswire
06:45AM  Mallinckrodt to Present at Piper Jaffray Annual Healthcare Conference PR Newswire
Nov-18-19 10:18PM  Value Investor Bill Millers New Stock Picks Insider Monkey
Nov-13-19 07:10AM  The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher Benzinga
Nov-12-19 04:30PM  Mallinckrodt Announces New Clinical Data Evaluating Acthar® Gel (Repository Corticotropin Injection) in Rheumatoid Arthritis (RA) at the 2019 American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) Annual Meeting PR Newswire
Nov-11-19 03:30PM  Mallinckrodt Presents Positive Phase 3 Results from its CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019 PR Newswire -8.04%
Nov-08-19 06:45AM  Mallinckrodt to Present at Jefferies London Healthcare Conference PR Newswire
Nov-07-19 06:45AM  Mallinckrodt Announces Data Publication on the Treatment Effectiveness of Acthar® Gel (Repository Corticotropin Injection) for Resolution of Multiple Sclerosis Relapse in a U.S. Health Plan Population PR Newswire
Nov-06-19 12:37PM  Teva earnings preview: Opioid suits are key MarketWatch -9.31%
10:41AM  Mallinckrodt International Finance SA -- Moody's: Mallinckrodt's debt exchange offer will likely be viewed as a distressed exchange Moody's
10:41AM  Mallinckrodt (MNK) Q3 Earnings Beat, Stock Down on Sales Miss Zacks
Nov-05-19 06:23PM  Mallinckrodt receives SEC subpoena over Acthar gel lawsuit Reuters -13.51%
09:47AM  Mallinckrodt Stock Is Sinking as Sales Fall Well Short of Expectations Barrons.com
07:35AM  Mallinckrodt (MNK) Q3 Earnings Beat Estimates Zacks
06:41AM  Mallinckrodt's stock falls after adjusted profit beat, but sales fell below forecasts MarketWatch
06:05AM  Mallinckrodt plc Announces Exchange Offers and Consent Solicitations PR Newswire
06:00AM  Mallinckrodt plc Reports Earnings and Pipeline Advancements for the Third Quarter 2019 and Raises Adjusted Diluted Earnings Per Share Guidance Range for 2019 PR Newswire
Nov-04-19 04:30PM  Mallinckrodt Completes Sale of BioVectra Inc. for up to $250 Million PR Newswire +13.91%
01:09PM  Preview: Mallinckrodt's Q3 Earnings Benzinga
Nov-01-19 11:05AM  Is a Beat in the Cards for Mallinckrodt (MNK) in Q3 Earnings? Zacks +6.96%
09:24AM  Hedge Funds Have Never Been Less Bullish On Mallinckrodt (MNK) Insider Monkey
07:38AM  The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance Benzinga
Oct-31-19 04:35PM  Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults PR Newswire
Oct-30-19 11:46AM  Mylan (MYL) to Report Q3 Earnings: What's in the Offing? Zacks -6.33%
Oct-29-19 10:33AM  Analysts Estimate Mallinckrodt (MNK) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-25-19 11:07AM  Two charities to pay $6 million to resolve U.S. pharma kickback probe Reuters +5.63%
Oct-24-19 10:10AM  Why Mallinckrodt (MNK) Could Beat Earnings Estimates Again Zacks -5.63%
Oct-22-19 10:58AM  Zacks.com featured highlights include: Mallinckrodt, Sony and Public Storage Zacks +12.60%
10:42AM  Top Ranked Growth Stocks to Buy for October 22nd Zacks
Oct-21-19 04:45PM  Mallinckrodt Raises Awareness of Critical Role Respiratory Therapists Play in Patient Care During Respiratory Care Week PR Newswire
12:24PM  J&J (JNJ) Recalls Baby Powder Batch as FDA Finds Asbestos Zacks
10:15AM  Mallinckrodt to Present Results from its Pivotal Phase 3 CONFIRM Study of Terlipressin in Patients with Hepatorenal Syndrome Type 1 (HRS-1) at The Liver Meeting® 2019 PR Newswire
09:55AM  Top 3 ROE Stocks to Profit as Earnings Season Heats Up Zacks
09:12AM  Will Mallinckrodt Continue to Surge Higher? Zacks
Oct-18-19 11:02AM  Is the Options Market Predicting a Spike in Mallinckrodt (MNK) Stock? Zacks
Oct-16-19 11:56AM  Opioid Drug Companies Rally On Hopes of Broader Settlement Benzinga +7.69%
Oct-09-19 06:45AM  Mallinckrodt to Report Earnings Results for Third Quarter 2019 PR Newswire -6.94%
Oct-03-19 11:16AM  J&J Settles Ahead of Multi-District Opioid Trial, Stock Up Zacks +8.64%
Mallinckrodt plc, together with its subsidiaries, develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies in the United States, Europe, the Middle East, Africa, and internationally. It operates in two segments, Specialty Brands, and Specialty Generics and Amitiza. The company markets branded pharmaceutical products for autoimmune and rare diseases in the areas of neurology, rheumatology, nephrology, ophthalmology, and pulmonology; and immunotherapy and neonatal respiratory critical care therapies, as well as analgesics and gastrointestinal products. It offers H.P. Acthar Gel, an injectable drug for rheumatoid arthritis, multiple sclerosis, infantile spasms, systemic lupus erythematosus, polymyositis, and others; Inomax, a vasodilator to enhance oxygenation and reduce the need for extracorporeal membrane oxygenation; Ofirmev, an intravenous formulation of acetaminophen for pain management; and Therakos photopheresis, an immunotherapy treatment platform. The company is also developing Terlipressin for the treatment of hepatorenal syndrome; StrataGraft, which is in Phase III and II clinical development for the treatment of burns; Stannsoporfin, a heme oxygenase inhibitor for the treatment of jaundice; Xenon gas for inhalation; MNK-6105 and MNK-6106, an ammonia scavenger for the treatment of hepatic encephalopathy, a neuropsychiatric syndrome associated with hyperammonemia; VTS-270 that is in Phase III development for Niemann-Pick Type C, a neurodegenerative disease; and CPP-1X/sulindac, which is in Phase III development for Familial Adenomatous Polyposis. It markets its branded products to physicians, pharmacists, pharmacy buyers, hospital procurement departments, ambulatory surgical centers, and specialty pharmacies. Mallinckrodt plc has collaboration with the Washington University School of Medicine and Silence Therapeutics plc. The company was founded in 1867 and is based in Staines-Upon-Thames, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Reasons Bryan M.EVP & CFOJun 07Buy8.965,40048,38317,979Jun 07 04:12 PM
Trudeau MarkPresident and CEOMay 30Buy9.262,00018,528233,254May 31 07:05 AM
Trudeau MarkPresident and CEOMay 09Buy16.331,00016,325231,254May 10 08:06 AM
Trudeau MarkPresident and CEOMar 05Buy22.651,00022,650229,252Mar 06 08:18 AM